Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin and Bevacizumab in Advanced Soft-Tissue Sarcoma
NCT00052390Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Oct 2002
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in soft tissue sarcoma (STS), sponsored by Memorial Sloan Kettering Cancer Center. Started Oct 2002; status: completed.
02
Drugs
bevacizumab
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00052390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052390.